Prolonged intensive care unit (ICU) stay after cardiac surgery leads to potential reduction in quality of life and incremental use of resources. For efficient use of ICU resources and to schedule patients with a low risk of postoperative complications before patients with a higher risk, preoperative estimation of the risk of prolonged ICU stay is necessary. Various prediction models have been developed to preoperatively identify patients with an increased risk for prolonged ICU stay. It is widely accepted that no prediction model should be applied in practice before being formally validated in new patients. In the domain of prolonged ICU stay after cardiac surgery, however, no study has thus far conducted such a formal validation and comparison study. The present analysis is the first extensive quantitative validation of existing models for prolonged ICU stay after cardiac surgery in a large data set of 11 395 patients. The results show that the Parsonnet model and the European system for cardiac operative risk evaluation (EuroSCORE) have the overall best performance. Although both models were originally developed to predict mortality, they are also superior in identifying patients with an increased risk of prolonged ICU stay. Because in current daily practice both models are widely implemented for the estimation of mortality risk, this allows for a relatively straightforward application of our findings in clinical practice. The risk stratification for mortality based on these models can also be used to identify patients with an increased risk of prolonged ICU stay, which is useful for timely planning of postoperative care and ICU management. See p 682.
Cardiac Index Is Associated With Brain Aging: The Framingham Heart Study
This cross-sectional observational study of 1504 communitydwelling, ambulatory adults (age, 34 to 84 years) is among the first epidemiological studies to examine the association between cardiac index and magnetic resonance imaging and neuropsychological markers of brain aging. Individuals in the top tertile of cardiac index (ie, values Ͼ2.9 L ⅐ min Ϫ1 ⅐ /mϪ2 ) had a significantly higher mean total brain volume, equivalent to nearly 2 years of healthier brain aging, compared with those individuals in the middle (2.5 to 2.9 L ⅐ min Ϫ1 ⅐ /mϪ2 ) or bottom (Ͻ2.5 L ⅐ min Ϫ1 ⅐ /mϪ2 ) cardiac index tertile. These findings suggest that in addition to low cardiac index (Ͻ2.5), a range of low-normal cardiac index values (2.5 to 2.9) may be related to compromised brain health integrity (as defined as total brain volume). If a reduced cardiac index is confirmed by other studies to be a risk factor for abnormal brain aging, then early identification of individuals with low or low normal cardiac index values may have important implications for the prevention and treatment of abnormal brain changes, including delaying or preventing the onset of dementia in older adults. See p 690.
Prevalence and Clinical Significance of Aortic Root Dilation in Highly Trained Competitive Athletes
The aorta is exposed to hemodynamic stress during endurance or power exercise training, which is associated with substantial increases in cardiac output and blood pressure. It is therefore plausible that significant aortic root remodeling may occur in highly trained athletes. The distribution of aortic dimension, prevalence, and clinical significance of aortic dilatation were investigated in 2317 highly trained athletes (56% male) free of cardiovascular disease. In males, aortic root was 23 to 44 mm (32.2Ϯ2.7), with 99th percentile of 40 mm; in females, aortic root was 20 to 36 mm (27.5Ϯ2.6), with 99th percentile of 34 mm. Only 1.3% of male and 0.9% of female athletes showed aortic root enlargement above the threshold values of 40 mm and 34 mm, respectively. Multivariable analysis showed that sports per se had only a limited influence on aortic dimension, whereas a more substantial impact was attributable to age, height, weight, and sex. In male athletes with enlarged aorta (Ն40 mm), further dimensional increase (40.9Ϯ1.3 to 42.9Ϯ3.6 mm; PϽ0.01) occurred over an 8Ϯ5-year follow-up, including 3 athletes in whom the aorta dilated substantially (to 50, 50, and 48 mm) after 15 to 17 years of follow-up in the absence of systemic disease, underscoring the importance of continued clinical surveillance. In female athletes, changes in aortic dimension over time were trivial and did not raise clinical concern. In conclusion, aortic root dimension Ն40 mm (and Ն34 mm in females) is very uncommon, occurring in only Ϸ1% of a large population of highly trained athletes, and does not represent an expression of physiological cardiac remodeling (ie, athlete's heart). See p 698.
Exercise Training Stimulates Ischemia-Induced Neovascularization via Phosphatidylinositol 3-Kinase/Akt-Dependent Hypoxia-Induced Factor-1␣ Reactivation in Mice of Advanced Age
Aging is associated with a decreased ability to form new vasculature in response to hypoxia, which results in diminished capacity for tissue regeneration. Previous clinical and experimental investigations have shown that exercise stimulates the vascular response to pathological conditions in humans and animals of young or advanced age; however, the molecular mechanisms by which exercise improves the aging-associated impairment in the hypoxia-induced factor (HIF)-1␣-mediated response to hypoxia are poorly understood. In the present study, we first showed that swimming training (ST) modulates the vascular response to ischemia in aged mice. ST improved the age-impaired recovery of not only blood reperfusion and capillary formation but also the levels of p-Akt, HIF-1␣, vascular endothelial growth factor, and matrix metalloproteinase-2 in wildtype mice of advanced age. ST also improved collateral vessel formation and reduced pathological vessel formation and foot amputation. Furthermore, data from cell therapy experiments confirmed that ST stimulates the mobilization of endothelial progenitor cells and the homing of these cells to the site of the ischemic vasculature associated with activation of HIF-1␣. All of these effects were diminished by LY2940029, an inhibitor of phosphatidylinositol 3-kinase; enhanced by deferoxamine, an HIF-1␣ stabilizer; and impaired by knockout of matrix metalloproteinase-2. Thus, therapeutic interventions with ST in advanced age restore the "young" hypoxic response and prevent age-associated declines in vascular regeneration by recruiting and improving delivery of endothelial progenitor cells to the vasculature through phosphatidylinositol 3-kinase signaling pathway-dependent HIF-1␣/vascular endothelial growth factor/matrix metalloproteinase-2 activation. We therefore conclude that a therapeutic ST intervention represents the complement of pharmacological or genetic interventions. See p 707.
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Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
Activation of the tissue and systemic renin-angiotensin system and the generation of angiotensin II play a key role in cardiovascular diseases. Angiotensin-converting enzyme 2 (ACE2) is the first known homolog of human ACE and functions as a pleiotropic monocarboxypeptidase. In the present study, we showed that ACE2 negatively regulates the pathophysiological effects of a pressor and subpressor dose of angiotensin II on myocardial structure and function. Whereas loss of ACE2 increases angiotensin II levels, increased ACE2 action by the use of recombinant human ACE2 lowered angiotensin II and increased angiotensin 1-7 levels in vivo, which provides definitive evidence for a key role of ACE2 in the metabolism of angiotensin II. These changes in peptide levels were associated with a plethora of molecular and cellular alterations, including inhibition of superoxide production and reduced activation of various key signaling pathways. The resultant phenotypic changes, characterized by increased myocardial and renal fibrosis, pathological hypertrophy, and diastolic dysfunction, were inhibited by ACE2. The beneficial effects of recombinant human ACE2 were also demonstrated in the clinically relevant model of pressureoverload-induced heart failure. In response to exogenous angiotensin II and pressure overload, ACE2 levels were decreased, thereby perpetuating the pathological effects of angiotensin II. The direct effects of angiotensin II on adult ventricular cardiomyocytes and cardiac fibroblasts were suppressed by recombinant human ACE2 in an angiotensin 1-7-dependent manner. Recombinant human ACE2 can provide a novel therapeutic approach for patients with cardiovascular disease. See p 717.
Intra-Arrest Transnasal Evaporative Cooling: A Randomized, Prehospital, Multicenter Study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness)
Therapeutic hypothermia has been shown to benefit survival in survivors of ventricular fibrillation or ventricular tachycardia, even when cooling is initiated with substantial delays in a hospital setting. Current guidelines from the American Heart Association and the International Liaison Committee on Resuscitation recommend cooling all such patients, and the use of cooling is becoming the standard of care in this setting. Many animal studies have shown significant added benefit when cooling is initiated earlier, with maximal benefit achieved when cooling is initiated during the arrest. Intra-arrest cooling has been shown to ease the resuscitation effort, increase resuscitation rates, and improve subsequent myocardial function. To date, intra-arrest cooling has not been studied in randomized human studies, largely because of the absence of methods suitable for use in the field. We have studied a new method of transnasal evaporative cooling that allows cooling to be initiated within minutes of the arrest and that has been shown to cool the brain before circulation is reestablished. The device previously has been shown to be safe for use in humans in an emergency room setting. In a randomized field study, we have shown that this method of cooling can be performed safely during an arrest without derailing the resuscitation effort and that it is relatively easy to implement. Furthermore, we have shown that target tympanic and core temperatures are achieved several hours earlier than with standard hospital-based cooling. Although outcomes are reported, larger studies will be required to determine the extent of the added outcome benefit over hospital-based cooling alone. See p 729.
Induction of Therapeutic Hypothermia by Paramedics After Resuscitation From Out-of-Hospital Ventricular Fibrillation Cardiac Arrest: A Randomized Controlled Trial
The induction of therapeutic hypothermia after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest is recommended for the treatment of neurological injury by the American Heart Association; however, the optimal timing of this intervention is uncertain. Laboratory studies suggest that earlier cooling may improve neurological outcomes. This study reports the results of a randomized controlled trial in 234 patients comparing paramedic cooling after return of a circulation by use of a rapid infusion of large-volume, ice-cold intravenous fluid with cooling after hospital arrival. Paramedic cooling decreased core temperature by 0.8°C compared with patients allocated to hospital cooling, but the outcomes at hospital discharge were similar in both groups. Further research into cooling during cardiopulmonary resuscitation should be undertaken. See p 737.
